GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Pre-Tax Income

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Pre-Tax Income : $ Mil (TTM As of Dec. 2022)


View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. CERo Therapeutics Holdings's pretax income for the six months ended in Dec. 2022 was $-11.83 Mil. CERo Therapeutics Holdings does not have enough years/quarters to calculate the pretax income for the trailing twelve months (TTM) ended in Dec. 2022. CERo Therapeutics Holdings's pretax margin was %.

CERo Therapeutics Holdings Pre-Tax Income Historical Data

The historical data trend for CERo Therapeutics Holdings's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings Pre-Tax Income Chart

CERo Therapeutics Holdings Annual Data
Trend Dec21 Dec22
Pre-Tax Income
-10.63 -11.83

CERo Therapeutics Holdings Semi-Annual Data
Dec21 Dec22
Pre-Tax Income -10.63 -11.83

Competitive Comparison of CERo Therapeutics Holdings's Pre-Tax Income

For the Biotechnology subindustry, CERo Therapeutics Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CERo Therapeutics Holdings's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CERo Therapeutics Holdings's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where CERo Therapeutics Holdings's Pre-Tax Income falls into.


CERo Therapeutics Holdings Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

CERo Therapeutics Holdings's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-11.971+0+0+0.142+0
=-11.83

CERo Therapeutics Holdings's Pretax Income for the quarter that ended in Dec. 2022 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-11.971+0+0+0.142+0
=-11.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CERo Therapeutics Holdings  (NAS:CERO) Pre-Tax Income Explanation

CERo Therapeutics Holdings's Pretax Margin for the quarter that ended in Dec. 2022 is calculated as

Pretax Margin=Pretax Income/Revenue
=-11.829/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CERo Therapeutics Holdings Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of CERo Therapeutics Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Pre-Tax Income
Comparable Companies
Traded in Other Exchanges
N/A
Address
201 Haskings Way, Suite 230, San Francisco, CA, USA, 94080
Website
https://www.cero.bio
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Headlines

From GuruFocus

CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients

By Business Wire • 03-07-2024